Stock Upgrades and Downgrades Calendar

View today's upgrades and downgrades and other equity ratings changes directly from brokerage firms.


Last Updated: 03-Jul-25 10:41 ET
Thursday, July 03
UPGRADES
FedEx  (FDX)
Brokerage Firm:  BNP Paribas Exane  |  Action:  Upgrade  |  Ratings Change:  Underperform » Outperform  |  Price Tgt:  $270
Huntington Banc  (HBAN)
Brokerage Firm:  Wolfe Research  |  Action:  Upgrade  |  Ratings Change:  Peer Perform » Outperform  |  Price Tgt:  $21
Meta Platforms  (META)
Brokerage Firm:  Needham  |  Action:  Upgrade  |  Ratings Change:  Underperform » Hold  |  Price Tgt:  --
UPS  (UPS)
Brokerage Firm:  BNP Paribas Exane  |  Action:  Upgrade  |  Ratings Change:  Underperform » Neutral  |  Price Tgt:  $100
Valley National  (VLY)
Brokerage Firm:  Morgan Stanley  |  Action:  Upgrade  |  Ratings Change:  Equal-Weight » Overweight  |  Price Tgt:  $11
DOWNGRADES
NV5 Global  (NVEE)
Brokerage Firm:  Maxim Group  |  Action:  Downgrade  |  Ratings Change:  Buy » Hold  |  Price Tgt:  --
PNC  (PNC)
Brokerage Firm:  Wolfe Research  |  Action:  Downgrade  |  Ratings Change:  Outperform » Peer Perform  |  Price Tgt:  --
Rio Tinto  (RIO)
Brokerage Firm:  Berenberg  |  Action:  Downgrade  |  Ratings Change:  Buy » Hold  |  Price Tgt:  --
Two Harbors Investment  (TWO)
Brokerage Firm:  Citizens JMP  |  Action:  Downgrade  |  Ratings Change:  Mkt Outperform » Mkt Perform  |  Price Tgt:  --
COVERAGE INITIATED
Prairie Operating Co.  (PROP)
Brokerage Firm:  KeyBanc Capital Markets  |  Action:  Initiated  |  Ratings Change:  Sector Weight  |  Price Tgt:  --
Primoris Services  (PRIM)
Brokerage Firm:  Janney  |  Action:  Initiated  |  Ratings Change:  Buy  |  Price Tgt:  --
Ralliant Corporation  (RAL)
Brokerage Firm:  BofA Securities  |  Action:  Initiated  |  Ratings Change:  Underperform  |  Price Tgt:  $48
Telix Pharmaceuticals  (TLX)
Brokerage Firm:  H.C. Wainwright  |  Action:  Initiated  |  Ratings Change:  Buy  |  Price Tgt:  $23
COVERAGE RESUMED
Absci Corporation  (ABSI)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $7
argenx  (ARGX)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $700
Ascendis Pharma  (ASND)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $250
Axsome Therapeutics  (AXSM)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $190
BioMarin Pharmaceutical  (BMRN)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $97
Certara  (CERT)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Equal-Weight  |  Price Tgt:  $16
Disc Medicine  (IRON)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $85
Kymera Therapeutics  (KYMR)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $70
Recursion Pharmaceuticals  (RXRX)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Equal-Weight  |  Price Tgt:  $5
Sana Biotechnology  (SANA)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Overweight  |  Price Tgt:  $12
Schrodinger   (SDGR)
Brokerage Firm:  Morgan Stanley  |  Action:  Resumed  |  Ratings Change:  Equal-Weight  |  Price Tgt:  $28
REITERATED/PRICE TARGET CHANGED
Crown  (CCK)
Brokerage Firm:  Citigroup  |  Action:  Reiterated  |  Ratings Change:  Buy  |  Price Tgt:  $119 » $129
DuPont  (DD)
Brokerage Firm:  Citigroup  |  Action:  Reiterated  |  Ratings Change:  Buy  |  Price Tgt:  $75 » $85
Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.